Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide, with an estimated global prevalence of 38% in adults. MASLD confers a significant increase in morbidity and mortality due to its association with cardi... ...
